Publisher: American Medical Association   (Total: 14 journals)   [Sort alphabetically]

Showing 1 - 14 of 14 Journals sorted by number of followers
JAMA The J. of the American Medical Association     Full-text available via subscription   (Followers: 2111, SJR: 8.876, CiteScore: 7)
JAMA Internal Medicine     Full-text available via subscription   (Followers: 194, SJR: 8.032, CiteScore: 4)
JAMA Pediatrics     Full-text available via subscription   (Followers: 127, SJR: 4.433, CiteScore: 4)
JAMA Psychiatry     Full-text available via subscription   (Followers: 108, SJR: 8.097, CiteScore: 8)
JAMA Neurology     Full-text available via subscription   (Followers: 65, SJR: 4.925, CiteScore: 5)
JAMA Ophthalmology     Full-text available via subscription   (Followers: 62, SJR: 2.776, CiteScore: 3)
JAMA Dermatology     Full-text available via subscription   (Followers: 50, SJR: 2.196, CiteScore: 2)
JAMA Surgery     Full-text available via subscription   (Followers: 43, SJR: 3.437, CiteScore: 3)
JAMA Cardiology     Hybrid Journal   (Followers: 42, SJR: 5.551, CiteScore: 5)
JAMA Oncology     Hybrid Journal   (Followers: 35, SJR: 6.187, CiteScore: 6)
JAMA Otolaryngology - Head & Neck Surgery     Full-text available via subscription   (Followers: 30, SJR: 1.462, CiteScore: 2)
JAMA Network Open     Open Access   (Followers: 7)
American medical news     Free   (Followers: 3)
JAMA Health Forum     Open Access  
Similar Journals
Journal Cover
JAMA Dermatology
Journal Prestige (SJR): 2.196
Citation Impact (citeScore): 2
Number of Followers: 50  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 2168-6068 - ISSN (Online) 2168-6084
Published by American Medical Association Homepage  [14 journals]
  • JAMA Dermatology

    • Free pre-print version: Loading...

      Pages: 347 - 347
      Abstract: Mission Statement: JAMA Dermatology publishes information concerning the skin, its diseases, and their treatment. Its mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician’s ability to diagnose and treat skin disorders. This journal has a particular interest in publishing clinical and laboratory studies that reveal new information pertinent to the interests and needs of the medical dermatologist, dermatologic surgeon, and all those concerned with state-of-the-art care of cutaneous disease. We believe that knowledge derived from well-designed clinical trials and studies of cost-effectiveness are especially important for improving the practice of dermatology. Studies that increase the understanding of the outcome of treatment or the means by which the burden of dermatologic disease can be measured and reduced to promote the health of patients with skin disease will receive special priority. The journal regularly publishes reports on clinical investigations, editorials, and reviews. It also features reports and discussions on clinicopathologic correlations; clinical disorders of unique didactic value; pharmacologic, medical and surgical therapeutics; and ethical, moral, socioeconomic, and political issues.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.4199
      Issue No: Vol. 158, No. 4 (2022)
       
  • Dermatologists and the Structural and Social Determinants of Health

    • Free pre-print version: Loading...

      Authors: Williams J; Amerson EH, Chang AY.
      Pages: 351 - 352
      Abstract: This Viewpoint considers the structural and social determinants of health in dermatology and suggests ways that dermatologists can use their roles as clinicians, advocates, researchers, and educators to improve health equity.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5925
      Issue No: Vol. 158, No. 4 (2022)
       
  • Why Diversity in Dermatology Clinical Trials Should No Longer Be Optional

    • Free pre-print version: Loading...

      Authors: Kamal K; Imadojemu S, Charrow A.
      Pages: 353 - 354
      Abstract: While race and ethnicity reporting in dermatology clinical trials has slightly improved in the last 5 years, the proportion of studies with adequate racial and ethnic diversity remains unchanged. Despite National Institutes of Health (NIH) diversity mandates and 2020 Food and Drug Administration (FDA) guidelines, dermatology continues to underreport race and ethnicity demographic data in clinical trials.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5190
      Issue No: Vol. 158, No. 4 (2022)
       
  • Ichthyosis Scoring System—A Powerful Tool in the Era of Immune
           Pathway–Targeted Therapies for Ichthyosis

    • Free pre-print version: Loading...

      Authors: Akiyama M.
      Pages: 354 - 356
      Abstract: Inherited ichthyoses are a group of rare genetic keratinization disorders characterized by generalized hyperkeratosis, scaling, and frequently erythema. These ichthyoses consist of nonsyndromic ichthyoses and ichthyosis syndromes, and more than 50 types of inherited ichthyoses are known. Usually, the skin symptoms of inherited ichthyoses have their onset at birth or in early infancy, and they typically persist for life. Although congenital ichthyoses are a group of rare diseases, most congenital ichthyoses involve severe symptoms in the skin and in various other organs that substantially affect patient quality of life.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5342
      Issue No: Vol. 158, No. 4 (2022)
       
  • The Promise and Pitfalls of Intravenous Gentamicin as a Therapy for
           Epidermolysis Bullosa

    • Free pre-print version: Loading...

      Authors: Bolling MC; Has C, Bruckner AL.
      Pages: 356 - 358
      Abstract: Epidermolysis bullosa (EB) is a rare inherited disorder of epithelial fragility, primarily manifesting as blisters and erosions of the skin and mucous membranes. Severe subtypes of EB can be complicated by recurrent or nonhealing wounds, scarring, and a range of nonskin complications that affect overall health and quality of life for individuals with the disorder. The current treatment of EB is largely palliative, relying on wound care, nutritional support, and symptom management. Although approaches such as genetically-corrected keratinocytes or fibroblasts are being investigated, particularly for recessive dystrophic EB, no disease-modifying therapy for EB is approved or widely available at this time, leaving tremendous unmet need for patients. The dystrophic epidermolysis bullosa research association (commonly known as debra), a patient advocacy organization, has characterized EB as “the worst disease you’ve never heard of” – a catchphrase that demands attention and signifies the isolation, pain, and suffering those with EB endure for the duration of their lives. The desperation for better treatments is palpable.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5630
      Issue No: Vol. 158, No. 4 (2022)
       
  • Development and Initial Validation of a Novel System to Assess Ichthyosis
           Severity

    • Free pre-print version: Loading...

      Authors: Sun Q; Asch S, Bayart C, et al.
      Pages: 359 - 365
      Abstract: This qualitative study describes a comprehensive and user-friendly instrument to measure total body ichthyosis severity in adults and children.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5917
      Issue No: Vol. 158, No. 4 (2022)
       
  • Gentamicin Outcomes for Patients With Junctional Epidermolysis Bullosa
           Caused by Nonsense Variants

    • Free pre-print version: Loading...

      Authors: Mosallaei D; Hao M, Antaya RJ, et al.
      Pages: 366 - 374
      Abstract: This nonrandomized clinical trial of patients with junctional epidermolysis bullosa assesses whether treatment with intravenous gentamicin can safely increase laminin 332 expression.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5992
      Issue No: Vol. 158, No. 4 (2022)
       
  • Association Between Short-term Exposure to Environmental Air Pollution and
           Psoriasis Flare

    • Free pre-print version: Loading...

      Authors: Bellinato F; Adami G, Vaienti S, et al.
      Pages: 375 - 381
      Abstract: This study examines whether there is an association between short-term exposure to air pollution and psoriasis flares.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.6019
      Issue No: Vol. 158, No. 4 (2022)
       
  • Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and
           Time From Diagnosis

    • Free pre-print version: Loading...

      Authors: McEvoy AM; Lachance K, Hippe DS, et al.
      Pages: 382 - 389
      Abstract: This cohort study estimates the risk of stage-specific Merkel cell carcinoma recurrence and mortality over time since diagnosis.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.6096
      Issue No: Vol. 158, No. 4 (2022)
       
  • Satellitosis or In-transit Metastasis in Cancer Staging Systems

    • Free pre-print version: Loading...

      Authors: Smile TD; Ruiz ES, Kus KB, et al.
      Pages: 390 - 394
      Abstract: This multi-institutional cohort study of patients with cutaneous squamous cell carcinoma examines the association of satellitosis or in-transit metastasis with clinical outcomes to determine prognostic implications.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0001
      Issue No: Vol. 158, No. 4 (2022)
       
  • Debt Valuations of Private Equity–Backed Dermatology Groups Before and
           During the COVID-19 Pandemic

    • Free pre-print version: Loading...

      Authors: Memon R; Memon A, Francis J, et al.
      Pages: 395 - 403
      Abstract: This cross-sectional study examines the valuations of dermatology private equity–backed group debt instruments in business development corporations’ portfolios both before and during the COVID-19 pandemic.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0009
      Issue No: Vol. 158, No. 4 (2022)
       
  • Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe
           Atopic Dermatitis

    • Free pre-print version: Loading...

      Authors: Simpson EL; Papp KA, Blauvelt A, et al.
      Pages: 404 - 413
      Abstract: This analysis of 2 randomized clinical trials evaluates long-term (52 weeks) efficacy and safety of upadacitinib treatment in patients with atopic dermatitis.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0029
      Issue No: Vol. 158, No. 4 (2022)
       
  • Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients

    • Free pre-print version: Loading...

      Authors: Sargen MR; Cahoon EK, Yu KJ, et al.
      Pages: 414 - 425
      Abstract: This cohort study examines the spectrum of disease and risk factors for nonkeratinocyte skin cancers in solid organ transplant recipients.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0036
      Issue No: Vol. 158, No. 4 (2022)
       
  • Estimating Overdiagnosis of Melanoma Using Trends Among Black and White
           Patients in the US

    • Free pre-print version: Loading...

      Authors: Adamson AS; Suarez EA, Welch H.
      Pages: 426 - 431
      Abstract: This cohort study used trends for mortality due to melanoma among Black patients in the US as a marker to estimate melanoma incidence among White patients in the US.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0139
      Issue No: Vol. 158, No. 4 (2022)
       
  • Skin Bias and Quality of Life Among Patients With Hidradenitis Suppurativa

    • Free pre-print version: Loading...

      Authors: Butt M; Rigby A, Leslie DL, et al.
      Pages: 432 - 438
      Abstract: This cross-sectional study of patients with hidradenitis suppurativa evaluates internalized skin bias to determine if it mediates the associations between adverse psychopathological outcomes and impaired health-related quality of life.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0248
      Issue No: Vol. 158, No. 4 (2022)
       
  • Gentamicin Repurposing as a Systemic Therapy for EBS-MD

    • Free pre-print version: Loading...

      Authors: Martínez-Santamaría L; Maseda R, de Arriba M, et al.
      Pages: 439 - 443
      Abstract: This case report examines the use of systemic gentamicin as a translational readthrough inducer for the treatment of epidermolysis bullosa simplex with muscular dystrophy owing to PLEC1 pathogenic nonsense variants.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0112
      Issue No: Vol. 158, No. 4 (2022)
       
  • Clinically Amyopathic Juvenile Dermatomyositis

    • Free pre-print version: Loading...

      Authors: Shawa H; Cotter DG.
      Pages: 445 - 445
      Abstract: This case report describes ragged cuticles; flat-topped pink papules overlying the bilateral metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints that were consistent with Gottron papules; and a spontaneous skin ulceration on the right knee.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5310
      Issue No: Vol. 158, No. 4 (2022)
       
  • Lupus Pernio

    • Free pre-print version: Loading...

      Authors: Popatia S; Wanat KA.
      Pages: 446 - 446
      Abstract: This case report describes violaceous papules on the nasal alae and medial periorbital skin, hypopigmented indurated plaques on the bilateral upper extremities and back, and verrucous plaques on the lower extremities and back.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.6007
      Issue No: Vol. 158, No. 4 (2022)
       
  • A Case of Unilateral Focal Hyperkeratosis

    • Free pre-print version: Loading...

      Authors: Tay W; Tee S, Cheng S.
      Pages: 447 - 448
      Abstract: A patient in their 50s presented with asymptomatic keratotic papules that had first appeared on the fingers and toes more than 10 years ago and then progressed proximally to areas on the left side of the body only. What is your diagnosis'
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.5931
      Issue No: Vol. 158, No. 4 (2022)
       
  • Generalized Micropapular Eruption in a Teenager

    • Free pre-print version: Loading...

      Authors: Rozas-Muñoz E; Terrasa-Sagrista F, Mir-Bonafé J.
      Pages: 449 - 450
      Abstract: A teenaged boy presented with a 1-year history of asymptomatic cutaneous lesions on the face that had spread to the trunk and extremities; he also had asthenia and mild intermittent arthralgias. What is your diagnosis'
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0066
      Issue No: Vol. 158, No. 4 (2022)
       
  • The ñ Sign as a Visual Clue for the Histopathologic Diagnosis of
           Psoriasis

    • Free pre-print version: Loading...

      Authors: Camporro Á; Roncero-Riesco M, Revelles-Peñas L, et al.
      Pages: 451 - 452
      Abstract: This qualitative study describes a visual clue for the diagnosis of psoriasis, in which the sum of the fragmentation and separation of the laminar parakeratotic stratum corneum and hyperplasia with regular elongation of the rete ridges resembles the letter ñ on histopathologic biopsy specimens.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0015
      Issue No: Vol. 158, No. 4 (2022)
       
  • Training and Practice Characteristics of IMGs in Dermatology

    • Free pre-print version: Loading...

      Authors: Kodumudi V; Cohen JM, Feng H.
      Pages: 452 - 454
      Abstract: This cross-sectional study uses demographic data from US health care and county sources to reveal training and practice characteristics of international medical graduates (IMGs) in dermatology.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0136
      Issue No: Vol. 158, No. 4 (2022)
       
  • Association of Treatment With Secukinumab With Exacerbation of
           Dermatomyositis in a Patient With Psoriasis

    • Free pre-print version: Loading...

      Authors: Perna DL; Callen JP, Schadt CR.
      Pages: 454 - 456
      Abstract: This case report describes a woman in her 20s with a history of psoriasis and juvenile dermatomyositis who presented for management of worsening psoriasis at a time when her juvenile dermatomyositis had been in remission for several years.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2021.6011
      Issue No: Vol. 158, No. 4 (2022)
       
  • Disseminated Herpes Infection Following Talimogene Laherparepvec
           Administration

    • Free pre-print version: Loading...

      Authors: Kimmis B; Luu Y, Dai H.
      Pages: 456 - 457
      Abstract: This case report describes a 69-year-old woman who received treatment with ipilimumab and talimogene laherparepvec therapy following metastasis of melanoma to the left inguinal lymph nodes, skin of left lower extremity, and vulva.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0020
      Issue No: Vol. 158, No. 4 (2022)
       
  • Treatment of Oral Erosive Lichen Planus With Upadacitinib

    • Free pre-print version: Loading...

      Authors: Balestri R; Bortolotti R, Rech G, et al.
      Pages: 457 - 458
      Abstract: This case report describes a 45-year-old woman who presented with painful oral erosions and chronic human leukocyte antigen B27–positive psoriatic peripheral arthritis with associated recurrent anterior uveitis.
      PubDate: Fri, 01 Apr 2022 00:00:00 GMT
      DOI: 10.1001/jamadermatol.2022.0147
      Issue No: Vol. 158, No. 4 (2022)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.236.234.223
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-